An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet (Avatrombopag) in Adult Patients With Immune Thrombocytopenia (ITP)
Latest Information Update: 09 Feb 2024
At a glance
- Drugs Avatrombopag (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- Acronyms ADOPT
- Sponsors Swedish Orphan Biovitrum
- 05 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 12 Dec 2023 Interim Results (as of July 2023, n=56)presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 02 Mar 2022 Status changed from not yet recruiting to recruiting.